STAT Plus: A stem cell company is touting a stroke survivor’s recovery. Its media blitz offers investors a mirage
ADOBE, DOM SMITH/STAT
A promotional campaign by Athersys, a small drug maker, for an experimental stem cell therapy ignores the available scientific evidence and clinical data.
No hay comentarios:
Publicar un comentario